Health Care & Life Sciences » Pharmaceuticals | Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC
Stock Exchange Other OTC
EPS
$0.31
Market Cap
$3.58 B
Shares Outstanding
102.33 M
Public Float
-
Dechra Pharmaceuticals PLC
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
102.33 M
Public Float
-
Dechra Pharmaceuticals PLC
Stock Exchange London Stock Exchange
EPS
GBP0.23
Market Cap
GBP2.86 B
Shares Outstanding
102.33 M
Public Float
96.84 M

Profile

Address
Cheshire Business Park
Northwich Cheshire CW9 7UA
United Kingdom
Employees -
Website http://dechra.com
Updated 07/08/2019
Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe.

Financials

View All

William Anthony Rice
Non-Executive Chairman
Ian Page
Chief Executive Officer & Executive Director